492 related articles for article (PubMed ID: 32466125)
1. Human Milk Oligosaccharide Supplementation Affects Intestinal Barrier Function and Microbial Composition in the Gastrointestinal Tract of Young Sprague Dawley Rats.
Chleilat F; Klancic T; Ma K; Schick A; Nettleton JE; Reimer RA
Nutrients; 2020 May; 12(5):. PubMed ID: 32466125
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Human Milk Oligosaccharide Supplementation During Critical Periods of Development on the Mesolimbic Dopamine System.
Noye Tuplin EW; Chleilat F; Alukic E; Reimer RA
Neuroscience; 2021 Apr; 459():166-178. PubMed ID: 33588004
[TBL] [Abstract][Full Text] [Related]
3. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
[TBL] [Abstract][Full Text] [Related]
4. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study.
Sprenger N; Lee LY; De Castro CA; Steenhout P; Thakkar SK
PLoS One; 2017; 12(2):e0171814. PubMed ID: 28182762
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
[TBL] [Abstract][Full Text] [Related]
7. HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related
Bajic D; Wiens F; Wintergerst E; Deyaert S; Baudot A; Van den Abbeele P
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049541
[TBL] [Abstract][Full Text] [Related]
8. Effect of supplementation with select human milk oligosaccharides on artificially reared newborn rats.
Wang W; Mu C; Cho NA; Noye Tuplin EW; Lowry DE; Chleilat F; Sales KM; Sampsell K; Shearer J; Reimer RA
Br J Nutr; 2022 Nov; 128(10):1906-1916. PubMed ID: 34963503
[TBL] [Abstract][Full Text] [Related]
9. 2'-fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice.
Lee S; Goodson M; Vang W; Kalanetra K; Barile D; Raybould H
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32260563
[TBL] [Abstract][Full Text] [Related]
10. The prebiotics 3'Sialyllactose and 6'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis.
Tarr AJ; Galley JD; Fisher SE; Chichlowski M; Berg BM; Bailey MT
Brain Behav Immun; 2015 Nov; 50():166-177. PubMed ID: 26144888
[TBL] [Abstract][Full Text] [Related]
11. Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants.
Paganini D; Uyoga MA; Kortman GAM; Boekhorst J; Schneeberger S; Karanja S; Hennet T; Zimmermann MB
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671757
[TBL] [Abstract][Full Text] [Related]
12. Blends of Human Milk Oligosaccharides Confer Intestinal Epithelial Barrier Protection in Vitro.
Natividad JM; Rytz A; Keddani S; Bergonzelli G; Garcia-Rodenas CL
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33027993
[TBL] [Abstract][Full Text] [Related]
13. Human Milk Oligosaccharides: Factors Affecting Their Composition and Their Physiological Significance.
Sprenger N; Binia A; Austin S
Nestle Nutr Inst Workshop Ser; 2019; 90():43-56. PubMed ID: 30865976
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed.
Wang M; Li M; Wu S; Lebrilla CB; Chapkin RS; Ivanov I; Donovan SM
J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):825-33. PubMed ID: 25651488
[TBL] [Abstract][Full Text] [Related]
15. Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function.
Šuligoj T; Vigsnæs LK; Abbeele PVD; Apostolou A; Karalis K; Savva GM; McConnell B; Juge N
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32933181
[TBL] [Abstract][Full Text] [Related]
16. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.
Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ
Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061
[TBL] [Abstract][Full Text] [Related]
17. Human milk oligosaccharide 2'-fucosyllactose supplementation improves gut barrier function and signaling in the vagal afferent pathway in mice.
Lee S; Goodson ML; Vang W; Rutkowsky J; Kalanetra K; Bhattacharya M; Barile D; Raybould HE
Food Funct; 2021 Sep; 12(18):8507-8521. PubMed ID: 34308934
[TBL] [Abstract][Full Text] [Related]
18. The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation.
Perdijk O; van Neerven RJJ; van den Brink E; Savelkoul HFJ; Brugman S
PLoS One; 2018; 13(7):e0200356. PubMed ID: 29990329
[TBL] [Abstract][Full Text] [Related]
19. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
[TBL] [Abstract][Full Text] [Related]
20. Select human milk oligosaccharide supplementation in post-weanling rats affects metabolism and gut microbiota into adulthood.
Noye Tuplin EW; Fernandes T; Lowry DE; Cho NA; Sales KM; Patterson RA; Reimer RA
Obesity (Silver Spring); 2023 May; 31(5):1362-1375. PubMed ID: 36998151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
